missing translation for 'onlineSavingsMsg'
Learn More
Learn More
![CXCR4 Antibody (Dana-Farber patent anti-CXCR4) [Janelia Fluor 635], Novus](https://assets.fishersci.com/TFS-Assets/CCG/Novus-Biologicals/product-images/novus_antibodies.jpg-650.jpg)
CXCR4 Antibody (Dana-Farber patent anti-CXCR4) [Janelia Fluor™ 635], Novus Biologicals™
Human Monoclonal Antibody
Marca: Novus Biologicals (Bio-Techne) NBP3-28800JF635
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
CXCR4 Monoclonal antibody specifically detects CXCR4 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Especificaciones
| CXCR4 | |
| Monoclonal | |
| Janelia Fluor 635 | |
| CD184, chemokine (C-X-C motif) receptor 4, chemokine (C-X-C motif), receptor 4 (fusin), C-X-C chemokine receptor type 4, CXC-R4, CXCR-4, D2S201ESDF-1 receptor, FB22, Fusin, HM89NPYRL, HSY3RR, LAP3, LCR1, LESTRCD184 antigen, Leukocyte-derived seven transmembrane domain receptor, leukocyte-derived seven-transmembrane-domain receptor, lipopolysaccharide-associated protein 3, neuropeptide Y receptor Y3, NPY3RWHIM, NPYR, NPYY3R, pCXCR4, seven transmembrane helix receptor, seven-transmembrane-segment receptor, spleen, Stromal cell-derived factor 1 receptor | |
| CXCR4/ CD184 | |
| 0.1 mL | |
| Adaptive Immunity, Cancer, Chemokines and Cytokines, Cytokine Research, GPCR, Growth and Development, Immunology, Innate Immunity, Metastasis, Neuronal Cell Markers, Signal Transduction, Stem Cells | |
| 7852 | |
| Store at 4°C in the dark. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| Dana-Farber patent anti-CXCR4 | |
| 50mM Sodium Borate | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Human | |
| Purified |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
CXCR4 Antibody (Dana-Farber patent anti-CXCR4) [Janelia Fluor™ 635], Novus Biologicals™ > 0.1 mL; Janelia Fluor 635
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido